Neuroptix Corporation

Management

Senior Management Team

Paul Hartung, President and CEO

Paul is a longtime life sciences executive with a proven track record in launching successful startup businesses and leading Fortune 500 organizations. He has extensive experience in the laser and medical device industries, including managing manufacturing for Summit Technology, Inc., a leading developer of the LASIK procedure and other laser eye correction procedures.

Prior to Cognoptix, Paul was Vice President of Operations at Winphoria Networks, a successful mobile communications startup acquired by Motorola. Before that he was Senior Director at 3Com Corporation, where he was involved in a number of mergers and acquisitions, and directed global operations and new product introductions. At Trumpf, he developed high power automated laser systems for industrial applications. As Director of R&D at Laser Fare Ltd., he developed new laser processing techniques for the medical device industry and other applications. Paul started his career as an Advanced Manufacturing Engineer at General Electric Company. He graduated from MIT with an MS Degree in Mechanical Engineering. He received the FW Taylor Award of the CIRP for his research.

Tom Trometer, Chief Financial Officer

With over 25 years of experience, and with a strong track record in CFO leadership positions, Tom is responsible for the financial management of Neuroptix’s operations. In this role he provides oversight for the financial management of the business, directs the corporate treasury function, establishes the protocols and standards for internal reporting, including Human Resources, and assists in building the business model and plan, shareholder communication, and risk management for the company. Prior to forming his own practice, he was VP Finance and CFO of CableSoft, and was instrumental in raising capital and selling the company to Motorola.  Before CableSoft, Tom was VP of Finance and Treasurer of Opta Food Ingredients, a public company, and was instrumental in raising over $40M in equity funds. He was also a manager in the Middle Market and Growing Companies Division of Price Waterhouse Coopers.  Tom is a CPA with a BS in accounting from Canisius College in Buffalo, NY.

Charles Kerbage, PhD, MBA, Director of Research and Development

Charles Kerbage has a strong record of scientific research that encompasses a multidisciplinary background. He possesses a rare combination of knowledge and technical skills in a number of disciplines. He has successfully conducted numerous studies and carried out pioneering work in optical waveguides at Bell Laboratories and Lucent Technologies. In addition, he developed devices for optical detection of cardiac arrhythmia as a postdoctoral fellow at Harvard University and constructed technologies for imaging ocular tissues that represent a quantum leap in biomedical applications as a research fellow at Wellman Center for Photomedicine at Massachusetts General Hospital. Prior to Cognoptix, Dr.Kerbage was a lead optical scientist at General Electric where he developed optical systems to detect infectious diseases at the point-of-care. Dr. Kerbage received his PhD in Applied Physics from the School of Engineering and Applied Sciences at Columbia University and an M.B.A. from the School of Management at Boston University. He was the recipient of the Robert Simon Memorial Prize for the most outstanding research with tremendous impact from Columbia University. Dr. Kerbage has authored and co-authored more than 50 peer-reviewed publications and holds several product related patents.

Anne Cameron, PhD, Director, Marketing and Clinical Strategy

Anne has 18 years experience in the pharmaceutical and diagnostics industry including research and development, marketing, regulatory and business development. At GE Healthcare, she led the Alzheimer’s disease PET imaging initiative, and was instrumental in business development deals with Roche and Eli Lilly.  Prior to GE, she held senior management positions at Roche. She has launched products within psychiatry and neurology. She has developed global strategies for product development in Alzheimer’s disease both for therapeutics and diagnostics. Anne has during her years working in psychiatry and neurology worked with a number of key opinion molders and advocacy groups and composed and directed more than 50 advisory board meetings. She has produced various publications within the field of CNS.